Divis Laboratories Ltd | DIVI - Current Liabilities

Stock Price
6,760.50
Daily Change
-161.00 -2.33%
Monthly
7.42%
Yearly
7.66%
Q2 Forecast
6,560.86

Divis Laboratories Ltd reported INR17.28B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Alaunos Therapeutics USD 595K 218K Mar/2026
Aurobindo Pharma INR 155.01B 8.18B Sep/2025
Avita Medical AUD 62.68M 77K Dec/2025
Dianthus Therapeutics USD 38.28M 7.55M Mar/2026
Divis Laboratories Ltd INR 17.28B 2.76B Sep/2025
Ionis Pharmaceuticals USD 717M 66M Mar/2026
IQVIA Holdings USD 8.33B 9M Mar/2026
Lupin INR 126.51B 18.31B Mar/2026
Moderna USD 2.4B 408M Mar/2026
Organon & Co USD 2.5B 110M Mar/2026
Revvity USD 1.24B 92.6M Mar/2026
Tectonic Therapeutic USD 12.96M 3.29M Mar/2026
Tilray USD 259.32M 8.32M Sep/2025
Viatris USD 6.81B 284M Mar/2026
Xeris Pharmaceuticals USD 118.59M 9.02M Mar/2026